Danaher Stock Soars on Q2 Earnings Beat

Danaher Corp. (DHR) hit analysts' expectations connected nan apical and bottommost lines pinch its second-quarter results, sending shares higher successful intraday trading Tuesday.

The life sciences institution posted adjusted earnings per stock (EPS) of $1.72 connected gross of $5.7 billion, topping Visible Alpha statement estimates of $1.58 and $5.58 billion. 

CEO Touts Strength successful Bioprocessing, Cepheid Units

"Our squad executed good during nan 2nd quarter, delivering better-than-expected revenue, net and rate flow,” Chief Executive Officer (CEO) Rainer Blair said. “We were peculiarly pleased pinch nan sustained affirmative momentum successful our bioprocessing business and pinch beardown capacity astatine Cepheid, which we judge gained marketplace stock successful molecular testing again this quarter."

Danaher besides affirmed its full-year projection that non-GAAP halfway gross will diminution by a low-single-digit percent year-over-year.

Shares of nan institution popped astir 7% to $267.55 arsenic of noon ET Tuesday. They are up much than 15% successful 2024.